tiprankstipranks
Larimar Therapeutics, Inc. (LRMR)
NASDAQ:LRMR
Holding LRMR?
Track your performance easily

Larimar Therapeutics (LRMR) Financial Statements

420 Followers

Larimar Therapeutics Financial Overview

Larimar Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.151; its P/E ratio is -5.28; Larimar Therapeutics is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -18.26M$ -24.60M$ -16.73M$ -14.16M$ -10.34M
EBITDA$ -18.19M$ -24.51M$ -16.65M$ -14.08M$ -10.26M
Net Income Common Stockholders$ -15.50M$ -21.63M$ -14.65M$ -12.99M$ -9.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 203.71M$ 226.06M$ 227.30M$ 86.79M$ 95.59M
Total Assets$ 219.02M$ 237.16M$ 248.21M$ 95.94M$ 103.95M
Total Debt$ 5.36M$ 5.59M$ 5.34M$ 5.55M$ 5.39M
Net Debt$ -198.34M$ -220.47M$ -221.95M$ -81.24M$ -90.20M
Total Liabilities$ 20.62M$ 25.76M$ 17.36M$ 14.21M$ 11.24M
Stockholders Equity$ 198.40M$ 211.44M$ 230.85M$ 81.72M$ 92.71M
Cash Flow-
Free Cash Flow$ -24.61M$ -14.26M$ -10.41M$ -9.51M$ -9.20M
Operating Cash Flow$ -24.55M$ -13.99M$ -10.41M$ -9.34M$ -9.20M
Investing Cash Flow$ 27.27M$ -63.49M$ -68.36M$ -2.63M$ -46.43M
Financing Cash Flow$ 30.00K$ -334.00K$ 162.15M-$ 30.00K
Currency in USD

Larimar Therapeutics Earnings and Revenue History

Larimar Therapeutics Debt to Assets

Larimar Therapeutics Cash Flow

Larimar Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis